A significant shift in federal health policy has been set in motion, as a new executive order prioritizes the scientific exploration of psychedelic compounds for therapeutic use. The directive instructs federal agencies, most notably the Food and Drug Administration, to streamline clinical trial processes and expand ‘Right to Try’ access for patients suffering from severe, […]